TMCnet News
Research and Markets: European Drug Delivery Technologies - Market Forecasts to 2017: The European Drug Delivery Market was Worth $39.9 Billion in 2012DUBLIN --(Business Wire)-- Research and Markets (http://www.researchandmarkets.com/research/g2rzj7/european_drug) has announced the addition of the "European Drug Delivery Technologies - Market Forecasts to 2017" report to their offering. This research report categorizes the European drug delivery market into oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal drug delivery. These markets are broken down into segments and sub-segments, providing exhaustive value analysis for 2010, 2011 and 2012, as well as forecast up to 2017. Each of the drug delivery markets is comprehensively analyzed at a granular level by geography (Germany, France, United Kingdom, Spain, Italy, Russia and Rest of Europe) to provide in-depth information on the European scenario of this market. The European drug delivery market was worth $39.9 billion in 2012. Over the years, drug delivery technologies have grown phenomenally from plain drug reformulation and release techologies, to innovative platforms that hold a huge potential for the effective delivery of biologicals and novel drugs. Patent expiration of certain blockbuster drugs, growing demand for self-administration and home healthcare devices, rising incidence of chronic diseases such as cardiovascular diseases, diabetes and cancer and growing focus on paediatric and geriatric patients are accelerating the growth of this market. However, drug failures and recalls and technical barriers are estimated to hamper this expansion. Over the years, drug delivery technologies have grown phenomenally from plain drug reformulation and release technologies to innovative platforms that hold a huge potential for the effective delivery of biologicals and novel drugs. Expanding applications of drug delivery into niche therapeutic areas, strategic collaborations and self-administration and home-care drug delivery devices represent vast opportunities for key players in this market. According to a 2012 report published by the World Economic Forum (WEF), the total geriatric population of Switzerland (aged 60 years and older) was 23% of the total population. This number is expected to increase to 32% by 2030 and to 37% by 2050. An increase in the number of geriatric patients and rise in demand for convenient drug delivery options pose major opportunities for the development of innovative and easy-to-use drug delivery systems. Companies Mentioned: - Alkermes, Inc - Becton, Dickinson And Company - Cima Labs - Dali Medical Devices - Foamix - Johnson & Johnson, Inc - Psivida Corporation - Skyepharma Plc - Valeant Pharmaceuticals - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/g2rzj7/european_drug About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. |
